2018 Interviews
Cell Culture Media Characterization Strategy and Related Challenges in Commercial Manufacturing
Min Zhang, PhD, Director, Manufacturing Sciences and Technology, AstraZeneca
Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. Min Zhang, Director of Manufacturing Sciences and Technology for AstraZeneca, about his upcoming presentation “Cell Culture Media Characterization Strategy and Related Challenges
in Commercial Manufacturing,” to be delivered in the Process Characterization and Control conference at the 2018 Bioprocessing Summit.
View the Interview
Challenges in Industrial-Scale Fill & Finish Operations for High-Concentration Proteins Formulations
Jean-René Authelin, PhD, Global Head of Pharmaceutical Engineering, Pharmaceutical Sciences, Sanofi France
Nandini Kashyap of Cambridge Healthtech Institute recently spoke with Dr. Jean-René Authelin of Sanofi about challenges in manufacturing and industrial-scale operations for high-concentration proteins formulations and where the industry is headed in coming years. Dr. Authelin is the keynote speaker at the 7th Annual High-Concentration Protein Formulations which is taking place on August 15-16, 2018 in Boston, MA where he will be delivering his talk on “Challenges in Industrial-Scale Fill & Finish Operations for High-Concentration Proteins Formulations.” This conference is being organized as part of the 10th Annual The Bioprocessing Summit which runs from August 13-17, 2018 in Boston, MA.
View the Interview
Quality by Design-Driven Approaches for Reaching Process Robustness
Dr. Christoph Herwig, Professor of Bioprocessing Engineering at Vienna University of Technology, and Founder and Scientific Advisor at Exputec GmbH recently shared insights on his upcoming presentation "Quality by Design-Driven Approaches for Reaching
Process Robustness", to be delivered at the 14th annual Optimizing Cell Culture Technology conference at the Bioprocessing Summit in Boston.
View the Interview
2017 Interviews
Developing Competitive Biologics Products Necessitates Combining Formulation Design, Process Development, and Device Integration
Yatin Gokarn, Ph.D., Head, Global Pharmaceutical Development Biologics, Sanofi Genzyme
There is an increasing need for designing and developing competitive biologics drug products in biotherapeutics marketplace when many new modalities and new product formats are making their way to market and many promising leads continue to fill the research
and development pipelines. A competitive patient-centric product necessitates a holistic product development strategy that takes into consideration formulation design, process development, analytics and device integration.
View the Interview
Translating Protein Expression Research to Biotech Startup Success and Bioprocess Goals
Tsafi Danieli, Ph.D., Director, BioGiv Excubator & Head, Protein Expression Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem
Mario Lebendiker, Ph.D., Head, Protein Purification Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem
Cambridge Healthtech Institute’s Ann Nguyen recently interviewed Tsafi Danieli, Ph.D. and Mario Lebendiker, Ph.D., Heads of the Protein Expression Facility and Protein Purification Facility, respectively, at Wolfson Centre for Applied Structural
Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem. They will instruct their upcoming training seminar on Basic Technologies in a Protein Production Lab August 21-22 at The Bioprocessing Summit in Boston.
View the Interview
Phase Appropriate Analytical Characterization of Recombinant Protein Based Vaccines
Vaneet K. Sharma, Ph.D., Analytical Scientist, Vaccine Development & Manufacturing, International AIDS Vaccine Initiative (IAVI)
Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. Vaneet Sharma, an Analytical Scientist in the Vaccine Development & Manufacturing group of International AIDS Vaccine Initiative (IAVI), about his upcoming presentation “Phase
Appropriate Analytical Characterization of Recombinant Protein Based Vaccines”, to be delivered at the Early Analytical Development for Biotherapeutics meeting being held as part of The Bioprocessing Summit in Boston.
View the Interview
Industry Approaches to Facility Segregation for Viral Safety
Paul Barone, Associate Director, BioMAN and CAACB, MIT Center for Biomedical Innovation
Cambridge Healthtech Institute recently spoke with Dr. Paul Barone of Massachusetts Institute of Technology about Viral Safety and where the field and industry is headed in coming years. Dr. Barone is a speaker at the 3rd Annual Virus and Pathogen Clearance
and Safety in Biologics which is taking place from August 24-25, 2017 in Boston, MA where he will be delivering his talk on “Industry Approaches to Facility Segregation for Viral Safety”. This conference is being organized as part of The
Bioprocessing Summit which runs from August 21-25.
View the Interview
Data Management in Process Development as a Key to Process Understanding and Development Efficiency
Martin Mayer, Ph.D., Director, evon GmbH, Austria
Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. Martin Mayer, a Director with Austria’s evon GmbH, Austria, about his upcoming presentation “Data Management in Process Development as a Key to Process Understanding
and Development Efficiency”, to be delivered in the Process Characterization and Control meeting at the 2017 Bioprocessing Summit. The Summit is scheduled for August 21-25 at the Westin Copley Place hotel in Boston, with the process charactertization
program set for August 24-25.
View the Interview
2016 Interviews
Epigenetic Effects on Antibody Production in CHO Cells
Susan Sharfstein, Ph.D., Associate Professor, Nanobioscience, Nanoscale Science and Engineering, SUNY Polytechnic Institute
Dr. Susan Sharfstein, Associate Professor of Nanoscale Science and Engineering at SUNY Polytechnic Institute, and a speaker at the upcoming Optimizing Cell Line Development conference shares insight on her presentation "Epigenetic Effects on Antibody
Production in CHO Cells".
View the Interview
Optimization, Simplification and Intensification of Cell Culture Processes
Jochen B. Sieck, Ph.D., Lab Head, Cell Culture Media R&D, Process Solutions R&D, Merck KGaA
Dr. Jochen B. Sieck, Lab Head of Cell Culture Media R&D, Process Solutions R&D, at Merck KGaA shares insight on his presentation "Optimization, Simplification and Intensification of Cell Culture Processes" to be featured at the upcoming Optimizing
Cell Culture Technology conference being held in Boston.
View the Interview
Plant-Wide Process Control Model for Biological Manufacturing
Richard D. Braatz is the Edwin R. Gilliland Professor of Chemical Engineering at MIT.
Cambridge Healthtech Institute’s Kent Simmons recently spoke with Richard D. Braatz about his upcoming presentation “Plant-Wide Process Control Model for Biological Manufacturing,” to be held August 19 in Boston as part of the Process
Characterization, Qualification and Control conference at the 8th Annual Bioprocessing Summit.
View the Interview | Download the PDF
Harmonizing Transient and Stable CHO Expression Platforms for Early-Phase Drug Discovery
Dr. Yashas Rajendra, Research Scientist of Bio-TDR Cell Culture at Eli Lilly and Company
Dr. Yashas Rajendra, Research Scientist of Bio-TDR Cell Culture at Eli Lilly and Company, and a speaker at the upcoming "Optimizing Cell Culture Technology Conference" shares insight on streamlining the discovery process by minimizing the risk
when molecules move forward in the portfolio.
View the Interview | Download the PDF